The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study

References

• Smith-Graziani D, Flowers CR. Understanding and addressing disparities in patients with hematologic malignancies: approaches for clinicians. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet. 2021; 41(41):1–7. http://www.ncbi.nlm.nih.gov/pubmed/33793311
   PubMedGoogle Scholar
• Patel MI, Lopez AM, Blackstock W, et al. Cancer disparities and health equity: a policy statement from the american society of clinical oncology. J Clin Oncol. 2020;38(29):3439–3448. doi:10.1200/JCO.20.00642
   PubMed Web of Science ®Google Scholar
• Shenoy PJ, Malik N, Nooka A, et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer [Internet]. 2011;117(11):2530–2540. doi:10.1002/cncr.25765
   PubMed Web of Science ®Google Scholar
• Flowers CR, Shenoy PJ, Borate U, et al. Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma. 2013; 54(2):268–276. doi:10.3109/10428194.2012.708751
   PubMed Web of Science ®Google Scholar
• Wang M, Burau KD, Fang S, et al. Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer [Internet]. 2008; 113(11):3231–3241. doi:10.1002/cncr.23914
   PubMed Web of Science ®Google Scholar
• Tao L, Foran JM, Clarke CA, et al. Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era. Blood [Internet]. 2014; 123(23):3553–3562. doi:10.1182/blood-2013-07-517110
   Google Scholar
• Pulte D, Jansen L, Brenner H. Survival disparities by insurance type for patients aged 15-64 years with non-Hodgkin lymphoma. Oncologist. 2015; 20(5):554–561. doi: 10.1634/theoncologist.2014-0386
   PubMed Web of Science ®Google Scholar
• Hall JM, Stevens PE, Meleis AI. Marginalization: a guiding concept for valuing diversity in nursing knowledge development. ANS Adv Nurs Sci. 1994;16(4):23–41. doi: 10.1097/00012272-199406000-00005
   PubMed Web of Science ®Google Scholar
• Baah FO, Teitelman AM, Riegel B. Marginalization: conceptualizing patient vulnerabilities in the framework of social determinants of health – an integrative review. Nurs Inq. 2019;26(1):e12268. doi: 10.1111/nin.12268
   PubMed Web of Science ®Google Scholar
• McDonald JT, Kennedy S. Insights into the ‘healthy immigrant effect’: health status and health service use of immigrants to Canada. Soc Sci Med. 2004;59(8):1613–1627. doi:10.1016/j.socscimed.2004.02.004
   PubMed Web of Science ®Google Scholar
• Cheung MC, Earle CC, Fischer HD, et al. Impact of immigration status on cancer outcomes in Ontario, Canada. J Oncol Pract. 2017;13(7):e602–e612. doi:10.1200/JOP.2016.019497
   PubMed Web of Science ®Google Scholar
• Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: a computer approach. IARC Sci Publ. 1991;(95):246–257. https://europepmc.org/article/med/1894327
   PubMedGoogle Scholar
• Johns Hopkins ACG® System [Internet]. [cited 2021 Nov 23]. Available from: https://www.hopkinsacg.org/.
   Google Scholar
• Flora Matheson AI, Moloney G. https://www.publichealthontario.ca/-/media/documents/O/2017/on-marg-userguide.pdf. [Internet]. [cited 2020 Oct 21]. Available from: https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/prof/details/download-.
   Google Scholar
• Moin JS, Moineddin R, Upshur REG. Measuring the association between marginalization and multimorbidity in Ontario, Canada: a cross-sectional study. J Comorb. 2018; 8(1):2235042X18814939. doi:10.1177/2235042X18814939
   PubMedGoogle Scholar
• Zygmunt A, Kendall CE, James P, et al. Avoidable mortality rates decrease but inequity gaps widen for marginalized neighborhoods: a population-based analysis in Ontario, Canada from 1993 to 2014. J Community Health. 2020;145(3):579–597. doi:10.1007/s10900-019-00778-8
   Google Scholar
• Buajitti E, Watson T, Norwood T, et al. Regional variation of premature mortality in Ontario, Canada: a spatial analysis. Popul Health Metr. 2019;17(1):9. doi:10.1186/s12963-019-0193-9
   PubMedGoogle Scholar
• McDonald E, Quick M, Oremus M. Examining the association between Community-Level marginalization and emergency room wait time in Ontario, Canada. Healthc Policy. 2020;15(4):64–76. doi:10.12927/hcpol.2020.26223
   PubMedGoogle Scholar
• Durbin A, Moineddin R, Lin E, Steele LS, Glazier RH. Examining the relationship between neighbourhood deprivation and mental health service use of immigrants in Ontario, Canada: a cross-sectional study. BMJ open. 2015; 5(3): e006690.
   Google Scholar
• Silverman JD, Hutchison MG, Cusimano MD. Association between neighbourhood marginalization and pedestrian and cyclist collisions in Toronto intersections. Can J Public Heal [Internet]. 2013;104(5):e405–9. doi:10.17269/cjph.104.4053.
   PubMed Web of Science ®Google Scholar
• Lachaud J, Donnelly PD, Henry D, Kornas K, Calzavara A, Bornbaum C, Rosella L. A population-based study of homicide deaths in Ontario, Canada using linked death records. International journal for equity in health. 2017 Dec;16:1-7
   Google Scholar
• Panarella M, Saarela O, Esensoy AV, et al. (Amy). Regional variation in palliative care receipt in Ontario, Canada. J Palliat Med. 2019;22(11):1370–1377. doi:10.1089/jpm.2018.0573
   PubMed Web of Science ®Google Scholar
• Dunn SF, Lofters AK, Ginsburg OM, et al. Cervical and breast cancer screening after CARES: a community program for immigrant and marginalized women. Am J Prev Med. 2017;52(5):589–597. doi:10.1016/j.amepre.2016.11.023
   PubMed Web of Science ®Google Scholar
• Kagedan DJ, Abraham L, Goyert N, et al. Beyond the dollar: influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer. Cancer [Internet]. 2016;122(20):3175–3182. doi:10.1002/cncr.30148
   PubMed Web of Science ®Google Scholar
• Knighton AJ, Savitz L, Belnap T, et al. Introduction of an area deprivation index measuring patient socioeconomic status in an integrated health system: implications for population health. eGEMs. 2016;4(3):9. doi:10.13063/2327-9214.1238
   Google Scholar
• van Ingen T, Matheson FI. The 2011 and 2016 iterations of the Ontario marginalization index: updates, consistency and a cross-sectional study of health outcome associations. Can J Public Health. 2021;1133(2):260–271. doi:10.17269/s41997-021-00552-1
   PubMed Web of Science ®Google Scholar
• Boslooper K, Hoogendoorn M, van Roon EN, et al. No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status. Cancer Epidemiol. 2017;48:110–116. doi:10.1016/j.canep.2017.04.009
   PubMed Web of Science ®Google Scholar
• Le Guyader-Peyrou S, Orazio S, Dejardin O, et al. Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? Haematologica [Internet]. 2017;102(3):584–592. doi:10.3324/haematol.2016.152918
   PubMed Web of Science ®Google Scholar
• Jin Y, Li J, Mun Y, et al. Racial, ethnic, and socioeconomic disparities in treatment outcomes in patients (pts) with diffuse large B-cell lymphoma (DLBCL): A U.S. real-world study using a de-identified electronic health record (EHR)-derived database. JCO. 2021 May; 39: e18514.
   Google Scholar
• Lee S, Seeger JD. Racial disparities in DLBCL: analysis of SEER data from 2010-2019.JCO. 2023 May; 41: e18552.
   Google Scholar
• Wasifuddin M, Ilerhunmwuwa NP, Becerra H, et al. Racial disparities in the incidence and survival outcomes in diffuse large B-cell lymphoma in adolescents and young adults. Blood. 2023;142(Supplement 1):384–384. doi:10.1182/blood-2023-191139
   Google Scholar
• Rosas D, Toro Velez E, Liu Q, et al. Racial and ethnic disparities for diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results (SEER) database analysis with emphasis on hispanics. Blood. 2022;140(Supplement 1):6695–6696. doi:10.1182/blood-2022-159201
   Google Scholar
• Yang F, Abraham A, Zhang J, et al. Socioeconomic disparities in diagnostic testing among patients with diffuse large B-cell lymphoma in the US. Blood. 2020;136(Supplement 1):6. doi:10.1182/blood-2020-134687
   PubMedGoogle Scholar
• Shah BK, Bista A, Shafii B. Disparities in receipt of radiotherapy and survival by age, sex and ethnicity among patients with stage I diffuse large B-cell lymphoma. Leuk Lymphoma. 2015;56(4):983–986. doi:10.3109/10428194.2014.940583
   PubMed Web of Science ®Google Scholar
• Olszewski AJ, Foran JM. Health insurance-related disparities in lymphoma survival are partly mediated by baseline clinical factors. Oncologist. 2015; 20(10):1223–1224. doi:10.1634/theoncologist.2015-0228
   PubMed Web of Science ®Google Scholar
• Vijenthira A, Mozessohn L, Nagamuthu C, Liu N, Blunt D, Alibhai S, Prica A, Cheung MC. Frailty is associated with increased one-year mortality in patients with newly diagnosed diffuse large-B-cell lymphoma: A population-based study. Blood. 2020 Nov 5;136:34-7.
   Google Scholar
• Cordoba R, Luminari S, Eyre TA. The use of frailty assessments in treating older adults with aggressive lymphomas. Br J Haematol. 2021;194(4):677–685. doi:10.1111/bjh.17384
   PubMed Web of Science ®Google Scholar